|
|
|
|
| LEADER |
00000cam a2200000 4500 |
| 001 |
1085607372 |
| 003 |
DE-627 |
| 005 |
20220514111715.0 |
| 007 |
tu |
| 008 |
880818s1987 xx ||||| t 00| ||und c |
| 035 |
|
|
|a (DE-627)1085607372
|
| 035 |
|
|
|a (DE-576)015607372
|
| 035 |
|
|
|a (DE-599)BSZ015607372
|
| 035 |
|
|
|a (OCoLC)310962842
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 088 |
|
|
|a SCNAC-100-1-3
|
| 245 |
1 |
0 |
|a Drug abuse treatment and prevention provisions of the Anti-Drug Act of 1986
|b hearing before the Select Committee on Narcotics Abuse and Control, House of Representatives; 100. Congress, 1. session, March 11, 1987
|
| 264 |
|
1 |
|a Washington
|b U.S. Government Print.Off.
|c 1987
|
| 300 |
|
|
|a III, 103 S.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 2
|2 pdager
|
| 655 |
|
7 |
|a Forschungsbericht
|0 (DE-588)4155043-2
|0 (DE-627)10467444X
|0 (DE-576)209815833
|2 gnd-content
|
| 710 |
2 |
|
|a USA
|b Congress
|b House of Representatives
|b Select Committee on Narcotics Abuse and Control
|0 (DE-588)1048583-1
|0 (DE-627)100142443
|0 (DE-576)191429007
|4 oth
|
| 951 |
|
|
|a BO
|
| ELC |
|
|
|b 1
|
| LOK |
|
|
|0 000 xxxxxcx a22 zn 4500
|
| LOK |
|
|
|0 001 2116543525
|
| LOK |
|
|
|0 003 DE-627
|
| LOK |
|
|
|0 004 1085607372
|
| LOK |
|
|
|0 005 20151023142721
|
| LOK |
|
|
|0 008 880818||||||||||||||||ger|||||||
|
| LOK |
|
|
|0 040
|a DE-21
|c DE-627
|d DE-21
|
| LOK |
|
|
|0 852
|a DE-21
|
| LOK |
|
|
|0 852 1
|c KB 18 A 3869
|9 00
|
| LOK |
|
|
|0 935
|a krim
|
| ORI |
|
|
|a SA-MARC-krimdoka001.raw
|
| SIG |
|
|
|a UB: KB 18 A 3869
|
